Описание
Biodistribution and pharmacokinetic data for curcumin nanoformulations are presented, highlighting enhanced brain delivery compared to free curcumin.
Figure 9
ChartSource Paper
Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.Cite This Figure
![Figure 9: Biodistribution and pharmacokinetic data for curcumin nanoformulations are presented, highlighting enhanced brain delivery compared to free curcumin.]() > Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." *International journal of molecular sciences*, 2020. PMID: [33375513](https://pubmed.ncbi.nlm.nih.gov/33375513/)
<figure> <img src="" alt="Biodistribution and pharmacokinetic data for curcumin nanoformulations are presented, highlighting enhanced brain delivery compared to free curcumin." /> <figcaption>Figure 9. Biodistribution and pharmacokinetic data for curcumin nanoformulations are presented, highlighting enhanced brain delivery compared to free curcumin.<br> Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." <em>International journal of molecular sciences</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33375513/">33375513</a></figcaption> </figure>